April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Corneal Curvature and Thickness Ater Treatment Wth UVA and Riboflavin Assessed by Optical Coherence Tomography
Author Affiliations & Notes
  • N. M. Ziebarth
    Biomedical Engineering, University of Miami, Coral Gables, Florida
    Ophthalmic Biophysics Center,
    Bascom Palmer Eye Institute, Miami, Florida
  • J. Dias
    Biomedical Engineering, University of Miami, Coral Gables, Florida
    Ophthalmic Biophysics Center,
    Bascom Palmer Eye Institute, Miami, Florida
  • M. Prabakar
    Biomedical Engineering, University of Miami, Coral Gables, Florida
    Ophthalmic Biophysics Center,
    Bascom Palmer Eye Institute, Miami, Florida
  • L. Lau
    Biomedical Engineering, University of Miami, Coral Gables, Florida
  • C. Rowaan
    Ophthalmic Biophysics Center,
    Bascom Palmer Eye Institute, Miami, Florida
  • S. Uhlhorn
    Ophthalmic Biophysics Center,
    Bascom Palmer Eye Institute, Miami, Florida
  • F. Manns
    Biomedical Engineering, University of Miami, Coral Gables, Florida
    Ophthalmic Biophysics Center,
    Bascom Palmer Eye Institute, Miami, Florida
  • S. Yoo
    Bascom Palmer Eye Institute, Miami, Florida
  • J.-M. A. Parel
    Ophthalmic Biophysics Center,
    Bascom Palmer Eye Institute, Miami, Florida
  • Footnotes
    Commercial Relationships  N.M. Ziebarth, None; J. Dias, None; M. Prabakar, None; L. Lau, None; C. Rowaan, None; S. Uhlhorn, None; F. Manns, None; S. Yoo, None; J.-M.A. Parel, None.
  • Footnotes
    Support  IMSD (JD); Florida Lions Eye Bank; NIH center grant P30-EY014801; Research to Prevent Blindness; Henri and Flore Lesieur Foundation (JMP)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4998. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. M. Ziebarth, J. Dias, M. Prabakar, L. Lau, C. Rowaan, S. Uhlhorn, F. Manns, S. Yoo, J.-M. A. Parel; Corneal Curvature and Thickness Ater Treatment Wth UVA and Riboflavin Assessed by Optical Coherence Tomography. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4998.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To quantify changes in curvature, asphericity and thickness induced in Eye-Bank corneas after cross-linking treatment with ultraviolet light and riboflavin.

Methods: : Two human cadaver eyes (one pair, 79 years old, 2 days postmortem) were used. The corneal thickness was restored to normal values by placing the whole globe, cornea side down, in 25% Dextran for 24 hours. The eyes were re-inflated to normal pressures by injecting 25% Dextran in the posterior chamber. Re-inflation does not significantly alter the corneal shape between 2mmHg and 140mmHg (Brenman et al, 2000). The epithelium was removed from both the eyes using alcohol and a cotton swap. The whole globes were imaged with a custom-built laboratory optical coherence tomography system. After images were acquired, one drop of 0.1% riboflavin solution (10mg riboflavin-5-phosphate in 10mL Dextran 20% solution) was placed on the cornea every 5 minutes for 30 minutes. The cornea was then irradiated for 30 minutes using UVA radiation at 378nm with an irradiance of 3mW/cm2. To maintain hydration of the cornea during irradiation, one drop of riboflavin solution was placed on the cornea every 5 minutes. The whole globes were imaged after treatment with the optical coherence tomography system. The anterior corneal surface profile was extracted from the images and the central 5mm was fit with a conic section to calculate curvature and asphericity. The central corneal thickness was calculated by dividing the optical distance between the signal peaks of the central A-line by 1.38.

Results: : Treatment with ultraviolet light and riboflavin results in a decrease in corneal curvature (6.98mm before versus 5.74mm after treatment; 6.20mm before versus 5.23mm after treatment), an increase in asphericity magnitude (-1.76 before versus -8.34 after treatment; -8.87 before versus -16.46 after treatment), and a decrease in thickness (476µm before versus 402µm after treatment; 431µm before versus 394µm treated).

Conclusions: : These results suggest that corneal crosslinking produces a steepening and thinning of the cornea.Support: IMSD (JD); Florida Lions Eye Bank; NIH center grant P30-EY014801; Research to Prevent Blindness; Henri and Flore Lesieur Foundation (JMP).

Keywords: keratoconus • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×